Kusajili – Clinical trials directory

Result of your search per sponsor: Dan Zandberg, MD

Woman and Man Max 99 years
Dan Zandberg, MD Update Il y a 4 ans

Reirradiation With MK-3475 (Pembrolizumab) in Locoregional Inoperable Recurrence or Second Primary Squamous Cell CA of the Head and Neck Eligible participants with locoregional inoperable recurrence or second primary squamous cell carcinoma of the head and neck will be treated with reirradiation combined with anti-PD-1 mAb ...

Country None
organs None
Specialty None

Opened trial

More information